Clinical Trials

Aegerion has several different ongoing and planned adult and pediatric clinical trials designed to evaluate our orphan drug candidate in genetic lipid disorders. Currently, we are conducting clinical trials to determine the safety and efficacy of our lead candidate, lomitapide for the treatment of homozygous familial hypercholesterolemia.

If you’d like to receive updates regarding new Aegerion sponsored clinical trials, please complete the Clinical Updates Form. If you'd like to speak with one of our clinical operations professionals about qualifying as a site, inquire about compassionate use INDs, or have other questions for our clinical staff, send us an e-mail at clinical@aegerion.com

If you would like more information about a trial or want to enroll in a trial, please visit www.clinicaltrials.gov. This government-sponsored Web site lists most ongoing trials including those for which enrollment is currently taking place. Information is searchable by company, by drug candidate, by specific indication and by disease area. For each trial, the investigator is named and enrollment information is provided if appropriate.